Publikationen

2016

• Function of the tumour suppressor protein merlin in neurons of the central nervous system
  Rübsam J
  Dissertation 2016, Jena, Germany
  
• The importance of nerve microenvironment for schwannoma development.
  Schulz A, Büttner R, Hagel C, Baader SL, Kluwe L, Salamon J, Mautner VF, Mindos T, Parkinson DB, Gehlhausen JR, Clapp DW, Morrison H
  Acta Neuropathol 2016, 132(2), 289-307
  
• Neuron-Specific Deletion of the Nf2 Tumor Suppressor Impairs Functional Nerve Regeneration.
  Schulz A, Büttner R, Toledo A, Baader SL, von Maltzahn J, Irintchev A, Bauer R, Morrison H
  PLoS One 2016, 11(7), e0159718
  
• Genetic Factors of the Disease Course After Sepsis: Rare Deleterious Variants Are Predictive.
  Taudien* S, Lausser* L, Giamarellos-Bourboulis EJ, Sponholz C, Schöneweck F, Felder M, Schirra LR, Schmid F, Gogos C, Groth S, Petersen BS, Franke A, Lieb W, Huse K, Zipfel PF, Kurzai O, Moepps B, Gierschik P, Bauer M, Scherag A, Kestler** HA, Platzer** M
  EBioMedicine 2016, 12, 227-38 * equal contribution, ** co-senior authors
  
• Attenuated LKB1-SIK1 signaling promotes epithelial-mesenchymal transition and radioresistance of non-small cell lung cancer cells.
  Yao YH, Cui Y, Qiu XN, Zhang LZ, Zhang W, Li H, Yu JM
  Chin J Cancer 2016, 35(1), 50
  

2015

• Inside-out Regulation of Ectodomain Cleavage of Cluster-of-Differentiation-44 [CD44] and of Neuregulin-1 requires Substrate Dimerization.
  Hartmann M, Parra LM, Ruschel A, Lindner C, Morrison H, Herrlich** A, Herrlich** P
  J Biol Chem 2015, 290(28), 17041-54 ** co-senior authors, 2015 Best of jbc Papers of the Week Winner
  
• Tumor suppressor NF2 blocks cellular migration by inhibiting ectodomain cleavage of CD44.
  Hartmann* M, Parra* LM, Ruschel A, Schubert S, Li Y, Morrison H, Herrlich** A, Herrlich** P
  Mol Cancer Res 2015, 13(5), 879-90 * equal contribution, ** co-senior authors
  
• Deficiency of the protein-tyrosine phosphatase DEP-1/PTPRJ promotes matrix metalloproteinase-9 expression in meningioma cells.
  Petermann A, Stampnik Y, Cui Y, Morrison H, Pachow D, Kliese N, Mawrin C, Böhmer FD
  J Neurooncol 2015, 122(3), 451-9
  
• Inhibition of RAS Activation Due to a Homozygous Ezrin Variant in Patients with Profound Intellectual Disability.
  Riecken LB, Tawamie H, Dornblut C, Buchert R, Ismayel A, Schulz A, Schumacher J, Sticht H, Pohl KJ, Cui Y, Reis A, Morrison* H, Jamra* RA
  Hum Mutat 2015, 36(2), 270-8 * equal contribution
  
• Small GTPase control by ERM proteins and their upstream regulator CPI-17 : implications for tumorigenesis
  Wiehl U
  Dissertation 2015, Jena, Germany